Comprehensive perioperative blood management in patients undergoing elective bypass cardiac surgery: Benefit effect of health care education and systematic correction of iron deficiency and anemia on red blood cell transfusion
- PMID: 39146724
- DOI: 10.1016/j.jclinane.2024.111560
Comprehensive perioperative blood management in patients undergoing elective bypass cardiac surgery: Benefit effect of health care education and systematic correction of iron deficiency and anemia on red blood cell transfusion
Erratum in
-
Corrigendum to "Comprehensive perioperative blood management in patients undergoing elective bypass cardiac surgery: Benefit effect of health care education and systematic correction of iron deficiency and anemia on red blood cell transfusion" [J Clin Anesth. 2024 Nov:98:111560. doi:10.1016/j.jclinane.2024.111560. Epub 2024 Aug 14].J Clin Anesth. 2025 Jan;100:111666. doi: 10.1016/j.jclinane.2024.111666. Epub 2024 Oct 29. J Clin Anesth. 2025. PMID: 39472266 No abstract available.
Abstract
Study objective: The aim of this study was to investigate the efficacy of a two-step patient blood management (PBM) program in red blood cell (RBC) transfusion requirements among patients undergoing elective cardiopulmonary bypass (CPB) surgery.
Design: Prospective, non-randomized, two-step protocol design.
Setting: Cardiac surgery department of Clinique Pasteur, Toulouse, France.
Patients: 897 patients undergoing for elective CPB surgery.
Interventions: We conducted a two-steps protocol: PBMe and PBMc. PBMe involved a short quality improvement program for health care workers, while PBMc introduced a systematic approach to pre- and postoperative correction of deficiencies, incorporating iron injections, oral vitamins, and erythropoiesis-stimulating agents.
Measurements: The PBM program's effectiveness was evaluated through comparison with a pre-PBM retrospective cohort after propensity score matching. The primary objective was the proportion of patients requiring RBC transfusions during their hospital stay. Secondary objectives were also analyzed.
Main results: After matching, 343 patients were included in each group. Primary outcomes were observed in 35.7% (pre-PBM), 26.7% (PBMe), and 21.1% (PBMc) of patients, resulting in a significant reduction (40.6%) in the overall RBC transfusion rate. Both the PBMe and PBMc groups exhibited significantly lower risks of RBC transfusion compared to the pre-PBM group, with adjusted odds ratios of 0.59 [95% CI 0.44-0.79] and 0.44 [95% CI 0.32-0.60], respectively. Secondary endpoints included reductions in transfusions exceeding 2 units, total RBC units transfused, administration of allogeneic blood products, and total bleeding volume recorded on Day 1. There were no significant differences noted in mortality rates or the duration of hospital stays.
Conclusions: This study suggests that health care education and systematic deficiency correction are associated with reduced RBC transfusion rates in elective CPB surgery. However, further randomized, controlled studies are needed to validate these findings and refine their clinical application.
Keywords: Anemia; Elective cardiac surgery; Erythropoiesis-stimulating agent; Iron deficiency; Red blood cell transfusion.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest All the authors declare no conflicts of interest.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
